Matias Mäenpää (Videobot) discusses European expansion plans, why pharma is a key growth vertical, and how interactive video is reshaping Customer Experience (CX).
Where do you stand today in your European expansion strategy, and which markets do you see as the highest priorities over the next 12 to 24 months?
With a focus on pharma marketers and HCP engagement teams, virtually all European countries are target markets — our audience is highly specialised.
The pharmaceutical industry seems to be a key growth area for Videobot. How important is this vertical to your business today, and what have you learned from serving pharma clients so far?
We see a strong product-market fit with the pharma sector. HCP communication is undergoing a major shift towards digital. Doctors want to focus on patients, making it difficult for pharmaceutical manufacturers to earn brand time. Interactive educational video content is the most effective way to serve doctors and capture their attention.
How is your vision of video as a lead-generation tool evolving, and what new opportunities or use cases do you see emerging to help companies drive stronger commercial results?
It has evolved significantly. Today, Videobot is more of an interactive video experience platform that brings every customer touchpoint to life. The goal is to improve CX in a strategic way — not just to have a standalone lead-collection tool. Content must enhance the customer experience at every step of the journey.
